Yolande du Toit
3PUBLICATIONS
13CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (3)
Sort by Publication Date:
|Jun 26, 2023
Impact of Pertuzumab and Ado-Trastuzumab Emtansine on Cumulative Avoidance of Recurrence Among Women Treated for Locally Advanced, Inflammatory, or Early-Stage Nonmetastatic HER2-Positive Breast Cancer in the United States.Jesse A Sussell, David J Press, Svenn A Hansen
|May 11, 2023
Real-World First-Line Use of Pertuzumab With Different Taxanes for Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: A Comparative Effectiveness Study Using US Electronic Health Records.Letizia Polito, Jinjoo Shim, Sara A Hurvitz
|Oct 27, 2022
Event-Free Survival in Patients with Early HER2-Positive Breast Cancer with a Pathological Complete Response after HER2-Targeted Therapy: A Pooled Analysis.Sandra M Swain, Harrison Macharia, Javier Cortes
Pageof 1
Frequent Collaborators
2 joint publications
Sandra M Swain
1 joint publications
Javier Cortes
1 joint publications
Chau Dang
1 joint publications
Pinuccia Valagussa
1 joint publications
Letizia Polito
1 joint publications
Sara A Hurvitz
1 joint publications
Eleonora Restuccia
1 joint publications
Thibaut Sanglier
1 joint publications
Jesse A Sussell
1 joint publications
David J Press
